|
Parameter
| |
Lower limit
|
Upper limit
| |
|
Kidney cancer incidence 40+ (per 100,000)
|
19.8
|
17.82
|
21.78
|
[22]
|
|
RCC incidence (over kidney cancer incidence)
|
90%
|
85%
|
95%
|
[24, 25]
|
|
RCC incidence at diagnosis (over RCC incidence)
|
20%
|
15%
|
25%
|
[24, 25]
|
|
RCC mortality (localized disease)
|
1.66%
|
1.49%
|
1.83%
|
[23]
|
|
Transition to advanced RCC (year 1)
|
13.18%
|
11.86%
|
14.49%
|
[20]
|
|
Transition to advanced RCC (years 2 and 3)
|
4.57%
|
4.11%
|
5.02%
|
[20]
|
|
Transition to advanced RCC (years 4 and 5)
|
1.92%
|
1.73%
|
2.11%
|
[20]
|
|
Transition to advanced RCC (year 6 and 7)
|
1.64%
|
1.48%
|
1.81%
|
[20]
|
|
Transition to advanced RCC (year 8 to 10)
|
1.26%
|
1.13%
|
1.38%
|
[20]
|
|
Advanced RCC of favorable or intermediate risk
|
89%
|
80.1%
|
97.9%
|
[26]
|
|
Transition to post-advanced RCC
|
100%
| | |
[7, 13]
|
